Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
RLYB	Rallybio Corp Manufacturing · Year ended 2025-12-31 · USD	$858.0K	-$8.98M	n/m	-15.5%	34.9%	-$1.59
RFL	Rafael Holdings, Inc. Manufacturing · Year ended 2025-07-31 · USD	$917.0K	-$30.52M	n/m	-31.0%	44.0%	-$1.04
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
DARE	Dare Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.03M	-$13.40M	n/m	-471.4%	n/m	-$1.20
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
NEUP	Neuphoria Therapeutics Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.17M	-$13.45M	n/m	-54.7%	-92.5%	-$3.06
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
VTGN	Vistagen Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.27M	-$69.69M	n/m	-196.2%	161.1%	-$1.83
IGC	IGC Pharma, Inc. Manufacturing · Year ended 2025-03-31 · USD	$1.27M	-$7.12M	-560.3%	-112.5%	-5.5%	-$0.09
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
NWBO	Northwest Biotherapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$1.38M	-$60.16M	n/m	n/a	-0.3%	-$0.04
ATXI	Avenue Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40M	-$2.91M	-207.2%	-158.8%	n/a	n/a
NRXP	NRX Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.45M	-$28.62M	n/m	n/a	n/a	n/a
RANI	Rani Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.63M	-$40.95M	n/m	-124.1%	58.9%	-$0.45
BIOE	Bio Essence Corp Manufacturing · Year ended 2025-12-31 · USD	$1.90M	$896.2K	47.2%	n/a	485.8%	n/a
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
KRSA	Korsana Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.07M	-$3.53M	-170.1%	-38.8%	3.7%	-$1.11
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
RNAC	Cartesian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.80M	-$130.30M	n/m	n/a	-92.8%	-$5.02
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
XBIO	Xenetic Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.98M	-$2.68M	-90.1%	-36.2%	19.0%	-$1.58
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
CAMP	Camp4 Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.50M	-$80.40M	n/m	-168.5%	436.5%	-$2.65

Rows per page: 2550 100